HNGE

Hinge Health, Inc.

Healthcare · $7.4B market cap

Verdict

We can't put a fair value on HNGE right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth—?
Sales growth41.7% a year✓
Free cash flow growth277.5% a year✓
Return on invested capital-18.4%✗

Follow HNGE

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds HNGE. In Q2 2026, 1 added. Who we track

Moves in Q2 2026

Added: First Eagle Investment Management

Insider activity

Since Sep 1, 2026: no open-market purchases, 15 sales worth $27.3M and 5 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Hinge Health, Inc.

Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential…

Medical - Healthcare Information Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works